Vivek Jayaram

Vivek Jayaram
Occupation	Co-founder and CTO of Vocality Health
Known for	Voice AI for medical language translation
Education	Harvard University (BA, magna cum laude) University of Washington (PhD in Computer Science)

Vivek Jayaram is an American technology entrepreneur and computer scientist who is the co-founder and chief technology officer (CTO) of Vocality Health (also known as Trava), a startup developing voice-based artificial intelligence for medical language translation. The company participated in Y Combinator's Winter 2025 batch.

Career

Jayaram holds a Bachelor of Arts degree, magna cum laude, from Harvard University. He subsequently pursued a PhD in computer science at the University of Washington, where his research focused on generative AI, including generative models and speech AI. In 2020, Jayaram and fellow PhD student John Thickstun were awarded a Qualcomm Innovation Fellowship for their work in source separation. He completed his PhD in 2025.

Before founding Vocality Health, Jayaram worked as a computer vision engineer at Second Spectrum and held an internship at Google, where he contributed to machine learning applications for music. He also co-founded Fulltrack AI, a computer vision platform for cricket that attracted over four million active users.

Jayaram co-founded Vocality Health alongside Brogan McPartland, who serves as chief executive officer. The company, which has also operated under the names Celebi AI and Scyther, develops AI-powered voice solutions for healthcare settings. Its primary product enables physicians to communicate with patients across language barriers by providing instant medical interpretation, reducing reliance on traditional in-person and telephone-based human translation services. The company describes the existing system of medical translation — which costs hospitals billions of dollars annually through call centers and in-person interpreters — as inadequate for serving non-English-speaking patients.

In addition to clinical interpretation, Vocality Health offers intelligent voice AI agents designed to handle patient telephone calls and take actions on behalf of patients, with the aim of reducing operational costs and improving patient satisfaction.

As of early 2025, Vocality Health had raised $500,000 in a pre-seed round, with Y Combinator and Pioneer Fund among its investors. The company had two employees and was based in Seattle, Washington.